← Browse by Condition
Medical Condition

t cell prolymphocytic leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07356245 Phase 2
Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Enrollment
44 pts
Location
United States
Sponsor
Jonathan Brammer
View Trial →